Résultats de la recherche - 273 results
Hybrid immunity to SARS-CoV-2 in kidney transplant recipients and hemodialysis patients.
des maladies Ziekten en gezondheid in kaart brengen Service: Réponse immunitaire Immuunrespons Immune response Manuscript versions: DOI: https://pubmed.ncbi.nlm.nih.gov/34554629/ Version: Published ...
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.
Ziekten en gezondheid in kaart brengen Service: Réponse immunitaire Immuunrespons Immune response Manuscript versions: DOI: https://pubmed.ncbi.nlm.nih.gov/35105642/ Version: Published Full text ...
Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes.
Maladies virales Virale ziekten Viral diseases Réponse immunitaire Immuunrespons Immune response Manuscript versions: Full text access: Public Access Full text language: English Category: A2 FOS ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study
explained by socioeconomic differences in the prevalence of chronic diseases. Further research is needed to explore if this difference could be related to a lower immune response of people with certain ...
The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff- study protocol description and presentation of preliminary findings on symptoms.
infections (ARI). However, little is known, about the impact of a previous or current infection on the other in terms of susceptibility, immune response, and clinical course. The aim of the “Prior Infection ...
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
# 2021-000673-83). Health Topics: Health and disease monitoring Surveillance de la santé et des maladies Ziekten en gezondheid in kaart brengen Service: Réponse immunitaire Immuunrespons Immune response Manuscript ...
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
rituximab, resulting in a 2-week hospital admission. CONCLUSION: The BNT162 b2 vaccine is well-tolerated in cancer patients under active treatment. However, the antibody response of immunized cancer patients ...
Species-Specific Humoral Immune Responses in Sheep and Goats upon Small Ruminant Lentivirus Infections Inversely Correlate with Protection against Virus Replication and Pathological Lesions.
response against immune-dominant regions of the capsid and surface proteins upon homologous infection, which was absent after heterologous infection. These results inversely correlated with protection ...
The Expression of Hemagglutinin by a Recombinant Newcastle Disease Virus Causes Structural Changes and Alters Innate Immune Sensing.
importance of thoroughly understanding the recombinant vaccines’ structural organization, functional characteristics, and elicited immune responses. Health Topics: Newcastle disease Ziekte van Newcastle ...
A Role for B Cells to Transmit Hepatitis C Virus Infection.
vaccine design. Health Topics: Health and disease monitoring Surveillance de la santé et des maladies Ziekten en gezondheid in kaart brengen Service: Réponse immunitaire Immuunrespons Immune response Manuscript ...